Skip to main content

Featured

FS visits biomedical firm in UK

Financial Secretary Paul Chan yesterday visited a biopharmaceutical company and the Royal College of Art, and attended a lunch hosted by the China-Britain Business Council, as part of his ongoing trip to London.   Mr Chan visited AstraZeneca and met the company’s senior management to learn about its drug research and development activities, as well as its latest expansion plans.   AstraZeneca indicated that following in-depth talks with Hong Kong’s Office for Attracting Strategic Enterprises, it plans to develop a research and development centre in Hong Kong and will engage in further discussion with relevant government departments on the matter.   The Financial Secretary then attended a roundtable luncheon held by the China-Britain Business Council, and met representatives of British enterprises that do business, or plan to do business, either in the Mainland or Hong Kong.   Mr Chan later visited the Royal College of Art, which collaborated with the Hong Kong Polytechnic Unive
Read more

577k vaccine doses given

About 577,200 doses of COVID-19 vaccines have been administered to the public, with about 487,000 people receiving their first dose and about 90,200 people getting their second dose.   Among those receiving the first dose of vaccines, about 330,400 people have received the Sinovac jab and about 156,600 people have received the BioNTech one.   For the second dose, about 83,100 people have received the Sinovac vaccine while about 7,100 people have been administered the BioNTech jab.   About 2,900 people received their first dose of the Sinovac vaccine under the COVID-19 Vaccination Programme today.   Among them, about 2,600 people received the jab at eight community vaccination centres (CVCs), while about 300 were inoculated at private doctors and clinics participating in the programme.   Around 6,600 people received their second dose of the Sinovac vaccine today, including about 5,200 people vaccinated at CVCs and about 1,400 people through private doctors and clinics.   For the BioNTech vaccine, about 5,200 people received their first dose at 21 CVCs and about 6,500 received their second dose.   The overall percentage of people who received the Sinovac vaccine at CVCs is about 96%, while that of the BioNTech vaccine is about 95%.   As of 8pm, about 2,500 people had reserved their first and second doses of the Sinovac vaccine online, while about 12,800 had reserved their first and second doses of the BioNTech vaccine.   As of midnight, one person was sent to hospital.
http://dlvr.it/Rx3KTt

Popular Posts